HOME >> MEDICINE >> NEWS
Widely used anti-nausea drug may interfere with cancer chemotherapy

A drug widely used to prevent nausea and other side effects in patients receiving chemotherapy for breast cancer may also, unfortunately, prevent the therapy from working efficiently on tumor cells, researchers from the University of Chicago report in the March 1 issue of the Journal, Cancer Research.

Dexamethasone, a synthetic steroid, is routinely given to women just before they receive chemotherapy with either paclitaxel or doxorubicin, two drugs commonly used to treat breast cancer. In this laboratory study, the researchers show that pretreatment with dexamethasone reduces the ability of paclitaxel and doxorubicin to kill cancer cells.

"Nearly every patient receiving chemotherapy for breast cancer also receives dexamethasone pre-treatments that may make therapy less effective," said Suzanne Conzen, M.D, assistant professor of medicine at the University of Chicago and director of the study. "With breast cancer one wants the best tumor reduction possible, but we have evidence that the benefits provided by routine treatment with dexamethasone may cause decreased chemotherapy-induced tumor cell death."

Conzen's team became suspicious nearly four years ago when they discovered that a group of steroid hormones know as glucocorticoids could inhibit death in certain cell types, including breast epithelial cells. This made them begin to question the wisdom of treating breast cancer patients with dexamethasone (known as Dex), an artificial glucocorticoid.

A careful search of the literature on dexamethasone uncovered another surprise. "Remarkably," the authors note, no clinical studies had ever addressed the potential effects on tumor response of administering Dex before routine chemotherapy for breast cancer.

To study these effects at the molecular level, Conzen's team devised a laboratory system that mimicked the usual clinical administration of dexamethasone in this setting. They found that pretreatment of breast cancer ce
'"/>

Contact: John Easton
jeaston@uchospitals.edu
773-702-6241
University of Chicago Medical Center
2-Mar-2004


Page: 1 2 3

Related medicine news :

1. Widely used breast cancer drug not linked to stroke
2. Widely used treatment for head injuries found to be harmful
3. Widely used anti-bacterial inhibits parasites that cause malaria and toxoplasmosis
4. Newest Depression Medications Widely Prescribed For Children
5. Widely Used Therapy May Not Be Effective In Treatment Of Acute Stroke
6. Personality, Thought To Be Stable Over Time, Changes In Healthy People Who Take A Widely Used Anti-Depressant
7. Research clarifies how Alzheimers medicines may reduce interference with learning and memory
8. Pain may interfere with depression improvement
9. Breast augmentation may interfere with mammography interpretation
10. Chronic stress can interfere with normal function of the immune system
11. Gasoline additive interferes with alcohol breath analyzers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/20/2019)... ... 20, 2019 , ... SightMD (or the “Company”), a leading ... strategic partnership with Northern Westchester Ophthalmology, P.C. (“NWO”) and its founding ophthalmologist Morris ... adding the Company’s first location in Westchester County to SightMD’s current footprint of ...
(Date:6/19/2019)... ... June 19, 2019 , ... The number of ... rigorous national standards of performance continues to climb. Today, the Public Health ... 11 local governmental public health departments. With this week's accreditation decisions, tens of ...
(Date:6/19/2019)... Mass. (PRWEB) , ... June 19, 2019 , ... ... 26th annual International Research Congress (IRC) in Marseille, France. The conference ... of state-of-the-art research on facioscapulohumeral muscular dystrophy (FSHD). Nearly 200 researchers, clinicians, industry ...
(Date:6/18/2019)... ... June 18, 2019 , ... EMulate Therapeutics, Inc. ... serious diseases, announced it has received notice that the US Food and Drug ... (HDE) for the Hælo Pediatric system. The FDA granted the Humanitarian Use ...
(Date:6/18/2019)... ... June 18, 2019 , ... ... today announced Steve Einig has joined the organization in the newly created role ... initiatives around market engagement, marketing, strategic events and brand management. , “Steve brings ...
Breaking Medicine News(10 mins):
(Date:6/16/2019)... R.I. (PRWEB) , ... June 15, 2019 , ... ... that afflicts 1.4% of the global population. The condition is characterized by ... further medical complications including thyroid disease, anemia, osteoporosis, fertility problems and some cancers, ...
(Date:6/14/2019)... ... June 14, 2019 , ... Akara ... Life Sciences Manufacturers accurately project their contracted liabilities with payers, providers and ... forecasting of rebates and discounts and dynamic scenario modeling in the ever-changing ...
(Date:6/13/2019)... ... June 13, 2019 , ... BESANA Health & Wellness ... center dedicated to realizing your optimal health, inside and out. Created by plastic ... Health & Wellness offers a range of wellness services, including functional health, physical ...
Breaking Medicine Technology:
Cached News: